SNN

Smith & Nephew plc
D

SNN

37.275
USD
-0.04
(-0.09%)
مفتوح الان
حجم التداول
4,353
الربح لكل سهم
2
العائد الربحي
2.01
P/E
33
حجم السوق
16,250,039,756
أصول ذات صلة
ABT
ABT
-0.800
(-0.61%)
130.690 USD
BAX
BAX
-0.055
(-0.22%)
24.460 USD
BDX
BDX
0.150
(0.08%)
194.230 USD
BSX
BSX
0.360
(0.34%)
106.810 USD
EW
EW
0.290
(0.36%)
81.550 USD
ILMN
ILMN
0.340
(0.34%)
99.000 USD
ISRG
ISRG
-1.11
(-0.23%)
473.26 USD
MDT
MDT
-0.410
(-0.44%)
91.680 USD
PODD
PODD
2.92
(0.88%)
334.66 USD
TMO
TMO
-4.89
(-1.00%)
483.81 USD
المزيد
الأخبار المقالات

العنوان: Smith & Nephew plc

القطاع: Healthcare
الصناعة: Medical Devices
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.